Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

NCT04610684 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of Enrollment

Conditions

Small-cell Lung Cancer
Brain Metastases

Interventions

DRUG: Carboplatin
DRUG: Etoposide
DRUG: Atezolizumab

Sponsor

Jeffrey Clarke

Collaborators

[object Object]
[object Object]